Ceretype Neuromedicine offers a next-generation fMRI brain biomarker platform that provides precise, millimeter-scale mapping of brain activity to enhance drug development and patient care in neuropsychiatry. By delivering actionable insights into brain circuitry, Ceretype addresses the lack of biological evidence in psychiatric treatment, enabling more effective and personalized therapeutic solutions.
Funding
$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
OMFounders
Product
Problem
Psychiatric and neurological disorder treatment currently lacks objective biological evidence, relying on subjective reports and trial-and-error methods. Existing functional MRI (fMRI) techniques have limitations in commercial translation, hindering the development of effective, personalized therapies. This absence of quantifiable brain-based biomarkers impedes accurate diagnosis, disease segmentation, and treatment efficacy assessment.
Solution
Ceretype Neuromedicine offers a next-generation fMRI brain biomarker platform that provides precise, millimeter-scale mapping of brain activity. The platform delivers actionable insights into brain circuitry, addressing the need for biological evidence in psychiatric and neurological treatment. Ceretype's technology enables accurate, reliable, and reproducible measurement of brain activity, quantifying fMRI images using advanced algorithms to correct artifacts. This allows for the creation of individual patient-level functional brain maps, facilitating disease segmentation and improved therapeutic solutions. The cloud-based platform integrates with existing data systems and offers decision support metrics for assessing brain function.
Target Audience
The primary users are drug and device developers, clinicians in psychiatry and neurology, and clinical researchers seeking objective biomarkers for diagnosis, treatment monitoring, and drug development.
Features
- High-resolution fMRI mapping of brain activity at the millimeter scale
- Advanced algorithms for artifact correction, ensuring reliable and reproducible results across scanners and individuals
- Brain Insight Report: functional brain map at the individual patient level
- Cloud-based platform for quantitation of fMRI images
- Decision support metrics: assessing brain function in multiple dimensions
- Integration with RIS or DICOM systems and interoperability with AI and data systems
- Ability to assess whole-brain, region-specific, and circuit-specific measurements of function and connectivity